751 related articles for article (PubMed ID: 8567767)
1. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
Tarlatzis BC; Grimbizis G; Pournaropoulos F; Bontis J; Lagos S; Spanos E; Mantalenakis S
Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
[TBL] [Abstract][Full Text] [Related]
2. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
3. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
4. [Effect of basal serum luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio on outcomes of in vitro fertilization-embryo transfer in patients with polycystic ovarian syndrome].
Geng X; Ou X; Liao Y; Tan W; Wang S; Quan S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):857-60. PubMed ID: 23803197
[TBL] [Abstract][Full Text] [Related]
5. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
Teissier MP; Chable H; Paulhac S; Aubard Y
Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
[TBL] [Abstract][Full Text] [Related]
8. Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation.
Cahill DJ; Prosser CJ; Wardle PG; Ford WC; Hull MG
Br J Obstet Gynaecol; 1994 Nov; 101(11):999-1002. PubMed ID: 7999732
[TBL] [Abstract][Full Text] [Related]
9. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
van Weissenbruch MM; Schoemaker HC; Drexhage HA; Schoemaker J
Hum Reprod; 1993 Jun; 8(6):813-21. PubMed ID: 8345068
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
Farhi J; Jacobs HS
Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
[TBL] [Abstract][Full Text] [Related]
11. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
[TBL] [Abstract][Full Text] [Related]
12. Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment.
Wiser A; Shehata F; Holzer H; Hyman JH; Shalom-Paz E; Son WY; Tulandi T
J Reprod Med; 2013; 58(5-6):219-23. PubMed ID: 23763006
[TBL] [Abstract][Full Text] [Related]
13. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
14. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.
Ganor-Paz Y; Friedler-Mashiach Y; Ghetler Y; Hershko-Klement A; Berkovitz A; Gonen O; Shulman A; Wiser A
J Endocrinol Invest; 2016 Jul; 39(7):799-803. PubMed ID: 26797707
[TBL] [Abstract][Full Text] [Related]
15. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.
Fleming R; Rehka P; Deshpande N; Jamieson ME; Yates RW; Lyall H
Hum Reprod; 2000 Jul; 15(7):1440-5. PubMed ID: 10875848
[TBL] [Abstract][Full Text] [Related]
16. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
Anderson RA; Groome NP; Baird DT
Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
[TBL] [Abstract][Full Text] [Related]
17. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
18. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
Li Y; Wei LN; Xiong YL; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
[TBL] [Abstract][Full Text] [Related]
19. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Gynecol Endocrinol; 2012 Jun; 28(6):422-4. PubMed ID: 22578028
[TBL] [Abstract][Full Text] [Related]
20. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
